Univec(OTC) UNVC

Market Cap$6.31M

Since IPO (1997)-100%

5 Year-97%

1 Year-4%

1 Month-19%

$0.00

+28.00%

+0.00Today

Univec last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-18

Univec stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-19.35%	USD 0.00	2026-08-11
1 month	-19.09%	USD 0.00	2026-07-17
3 month	+16.28%	USD 0.00	2026-05-20
Year to date	+0%	USD 0.00	2025-12-31
1 year	-3.85%	USD 0.00	2025-08-15
3 year	-77.68%	USD 0.01	2023-08-18
5 year	-97.36%	USD 0.09	2021-08-19
Since inception	-99.97%	USD 9.06	1997-04-24

Univec Financials at a Glance

Market Cap

$6.31M

Revenue (TTM)

$91.16K

Net Income (TTM)

-$1.22M

EPS (TTM)

-$0.00

P/E Ratio

-5.00

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Price

$0.00

Volume

371,499

Open

$0.00

Price

$0.00

Volume

371,499

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Price

$0.00

Volume

371,499

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

N/A

UNVC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Univec

Univec, Inc. is a medical device firm specializing in the development, licensing, and sale of innovative healthcare products. The company focuses on auto-disable and safety syringes, catering to both domestic and international markets.

Products and Services

Auto-disable syringes for precise medication dispensing
Sliding sheath syringes to prevent needlestick injuries
Bifurcated needle safety syringes for smallpox vaccinations

Growth Outlook

Recent quarterly revenue increased to $21,025, reflecting a positive trend
Gross profit margin improved to 8.97% in Q2 2026
Expansion into international markets presents significant growth opportunities

Financial Highlights

Trailing twelve months revenue of $83,764, indicating steady demand
Net income for Q2 2026 reported at -$311,471, showing ongoing operational challenges
Current liabilities significantly exceed current assets, highlighting liquidity concerns

AI Generated • Aug 19, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

David L. Dalton, PhD

Website

www.univechealth.com

Headquarters

Owings Mills, MD 21117, US

UNVC Financials

Key Financial Metrics (TTM)

Gross Margin

16.10%

Operating Margin

-1399.25%

Net Income Margin

-1334.32%

Return on Equity

6.83%

Return on Capital

N/A

Return on Assets

-3755.09%

Earnings Yield

-20.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.31M

Shares Outstanding

2.52B

Volume

371.50K

Avg. Volume

1.14M

Financials (TTM)

Gross Profit

$14.68K

Operating Income

-$1.28M

EBITDA

-$1.27M

Operating Cash Flow

-$15.55M

Capital Expenditure

-$2.00

Free Cash Flow

-$15.55M

Cash & ST Invst.

$0.00

Total Debt

$1.47M

Univec Performance Analysis

Univec annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 33,165	-38.2%
2023	2023-12-31	USD 21,044	-36.5%
2024	2024-12-31	USD 22,648	7.6%
2025	2025-12-31	USD 85,014	275.4%

Univec sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	86.8%
Q4	2025-12-31	-47.6%
Q1	2026-03-31	10.0%
Q2	2026-06-30	9.2%

Univec annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.00	57.1%
2023	2023-12-31	USD -0.00	-9.1%
2024	2024-12-31	USD -0.00	-70.0%
2025	2025-12-31	USD -0.00	66.7%

Univec sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	100.0%
Q4	2025-12-31	N/A
Q1	2026-03-31	N/A
Q2	2026-06-30	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$21.03K

+17.6%

Gross Profit

$1.89K

+346.7%

Gross Margin

8.97%

N/A

Market Cap

$6.31M

N/A

Market Cap/Employee

$2.10M

N/A

Employees

N/A

Net Income

-$311.47K

-1.4%

EBITDA

-$308.18K

-2.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$0.00

N/A

Total Debt

$1.47M

+16.0%

Accounts Receivable

$24.66K

+14.6%

Inventory

$0.00

N/A

Long Term Debt

$1.46M

+17.3%

Short Term Debt

$11.82K

-51.2%

Return on Assets

-37.55%

N/A

Return on Invested Capital

7.57%

N/A

Free Cash Flow

-$15.72K

-38.6%

Operating Cash Flow

-$15.72K

-38.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

OILFFNextleaf Solutions Ltd.

OILFFNextleaf Solutions Ltd.$0.04+15.43%

BGXXBright Green Corporation

BGXXBright Green Corporation$0.04+5328.57%

CRRTFCrescita Therapeutics, Inc.

CRRTFCrescita Therapeutics, Inc.$0.56+0.00%

AYRWFAyr Wellness Inc.

AYRWFAyr Wellness Inc.$0.00+0.00%

TWSITristar Wellness Solutions Inc.

TWSITristar Wellness Solutions Inc.$0.00+0.00%

CNFHFCanaFarma Hemp Products Corp.

CNFHFCanaFarma Hemp Products Corp.$0.00+0.00%

AUSAFAustralis Capital Inc.

AUSAFAustralis Capital Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

MRNAModerna

MRNAModerna$148.22+1.35%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$9.28+0.06%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$38.90+0.06%

INTCIntel

INTCIntel$93.72-0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.97+0.06%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$15.75+0.09%

SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF

SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF$46.18+0.04%

Questions About UNVC

What is the current price of Univec?

Univec is trading at $0.00 per share.

What is the 52-week range for Univec?

Over the past 52 weeks, Univec has traded between $0.00 and $0.01.

How much debt does Univec have?

As of the most recent reporting period, Univec reported total debt of $1.47M.

How much cash does Univec have on hand?

Univec reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Univec’s dividend yield?

Univec does not currently have a dividend yield.

Univec(OTC) UNVC

Univec Financials at a Glance

UNVC News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Univec

UNVC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Univec Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About UNVC

What is the current price of Univec?

What is the 52-week range for Univec?

How much debt does Univec have?

How much cash does Univec have on hand?

What is Univec’s dividend yield?

Premium Investing Services